RAY121
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RAY121, covering 2026-04-02 to 2026-04-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]